Open-Label, Multicenter, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous Anti-Claudin 18.2 Chimeric Antigen Receptor T-cell Therapy in Subjects with Advanced Gastric, Pancreatic, or Other Specified Digestive System Cancers

Protocol No
CARSGEN-CT041-ST-02
Phase
I/II
Summary

CAR-T (CT041) in Patients With Gastric or Pancreatic Cancer

Description
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Cancer, Stomach, Pancreas/Liver, Gastrointestinal Cancers, Esophagus
ClinicalTrials.gov
go to website